Aeva Technologies, Inc. — Form 8-K Summary
Business Context and Reporting Period
Aeva Technologies, Inc. filed this Current Report on March 18, 2024, reporting corporate actions affecting its common stock and publicly traded warrants. The filing does not provide operating or financial results for a reporting period.
Material Corporate Action
- The Company effected a 1-for-5 reverse stock split of its common stock at 4:01 p.m. Eastern Time on March 18, 2024.
- Trading of the post-split common stock began on the New York Stock Exchange at market open on March 19, 2024, under the existing ticker symbol “AEVA.”
- The post-split common stock received new CUSIP number 00835Q202. The par value, authorized share count, and other terms of the common stock were unchanged.
- Every five shares issued and outstanding were automatically combined into one share. Fractional shares were not issued; eligible holders will receive cash for fractional interests based on the net proceeds from their sale.
- The reverse split did not change stockholders’ proportional ownership interests, except for effects associated with fractional-share treatment.
Warrants and Equity Awards
- Outstanding equity awards, warrants, and shares available under equity plans and other applicable agreements were proportionately adjusted.
- For the Company’s publicly traded warrants, every five pre-split shares purchasable under a warrant became one post-split share, and the exercise price was multiplied by five.
- The exercise price of the publicly traded warrants under ticker “AEVA.WS” became $57.50. The warrants continued trading under the same symbol, and their CUSIP number was unchanged.
- Holders of shares in brokerage or street-name accounts generally were not required to take action; the accounts were to be adjusted automatically.
Financial Metrics, Liquidity, and Outlook
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or operating outlook information. It also does not report a change in fiscal year or any new financial contingency.
Key Investor Verification Items
- Confirm the effective date and 1-for-5 ratio of the reverse stock split.
- Verify post-split share balances, fractional-share cash treatment, and the new common-stock CUSIP.
- Confirm the adjusted terms of outstanding warrants and equity awards, including the $57.50 exercise price for the public warrants.
- Review Exhibit 3.1, the Certificate of Amendment, and Exhibit 99.1, the related press release, for the complete legal terms and disclosures.
- Assess any subsequent filings for the effect of the reverse split on share counts, market price, equity compensation, and warrant activity.